List of insiders holdings for ALEXION PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
2020-05-18 18:57:43 | 131,963 7,940,623 |
8,072,586 | Form 4 |
2 | BELL LEONARD Director |
2017-03-01 19:44:15 | 390,670 0 |
390,670 | Form 4 |
3 | Hallal David CEO |
2016-08-10 18:22:54 | 189,266 0 |
189,266 | Form 4 |
4 | MADRI JOSEPH A Director |
2014-03-13 17:03:48 | 179,217 0 |
179,217 | Form 4 |
5 | Sinha Vikas EVP & CFO |
2016-08-10 18:23:46 | 178,463 0 |
178,463 | Form 4 |
6 | KEISER DAVID W Director |
2009-06-03 14:15:21 | 149,546 0 |
149,546 | Form 4 |
7 | SQUINTO STEPHEN P EVP, Chief Global Ops. Officer |
2014-10-28 17:41:23 | 114,245 0 |
114,245 | Form 4 |
8 | Clancy Paul J EVP, Chief Financial Officer |
2019-07-15 17:01:00 | 90,447 0 |
90,447 | Form 4 |
9 | Moriarty John B EVP & General Counsel |
2018-02-08 19:16:24 | 74,537 0 |
74,537 | Form 4 |
10 | DUBIN THOMAS I H SVP & Chief Legal Officer |
2012-08-27 16:15:29 | 65,705 0 |
65,705 | Form 4 |
11 | Carmichael Clare EVP, Chief HR Officer |
2017-03-01 19:44:54 | 64,761 0 |
64,761 | Form 4 |
12 | MACKAY MARTIN EVP & Global Head of R&D |
2017-03-01 19:45:28 | 63,488 0 |
63,488 | Form 4 |
13 | O'Neill Julie EVP. Global Operations |
2018-03-02 16:59:44 | 51,727 0 |
51,727 | Form 4 |
14 | Wagner Heidi L SVP, Global Government Affairs |
2018-03-01 17:25:00 | 49,140 0 |
49,140 | Form 4 |
15 | Islam Saqib EVP, Chief Strat & Port. Off. |
2016-03-01 18:33:33 | 43,799 0 |
43,799 | Form 4 |
16 | LAW ANNE-MARIE EVP, Chief Experience Officer |
2020-06-09 17:01:29 | 41,423 0 |
41,423 | Form 4 |
17 | BOWDISH KATHERINE S Senior Vice President |
2005-06-15 16:46:02 | 40,196 0 |
40,196 | Form 4 |
18 | LUKE BARRY P VP, Finance & Administration |
2005-07-18 15:22:37 | 34,800 0 |
34,800 | Form 4 |
19 | Thiel Carsten EVP, Chief Commercial Officer |
2017-03-06 18:03:48 | 33,860 0 |
33,860 | Form 4 |
20 | MATHIS LARRY Director |
2014-03-04 17:38:53 | 30,351 0 |
30,351 | Form 4 |
21 | Miller Edward SVP, Chief Compliance Officer |
2017-03-01 19:45:46 | 27,984 0 |
27,984 | Form 4 |
22 | Waeger Ruedi E Director |
2010-05-05 15:40:14 | 24,054 0 |
24,054 | Form 4 |
23 | Wright Frank J SVP, President Alxn Pharm Intl |
2014-02-10 18:48:02 | 19,670 0 |
19,670 | Form 4 |
24 | MOJCIK CHRISTOPHER F SVP Clinical Development |
2007-05-31 20:53:12 | 14,152 0 |
14,152 | Form 4 |
25 | HANTSON LUDWIG CEO |
2021-07-23 16:32:28 | 9,098 0 |
9,098 | Form 4 |
26 | Monnet Dominique SVP, Chief Marketing Officer |
2015-05-22 17:30:32 | 8,787 0 |
8,787 | Form 4 |
27 | ANDERSON DAVID J EVP, Chief Financial Officer |
2016-12-13 18:24:23 | 8,689 0 |
8,689 | Form 4 |
28 | PARVEN ALVIN S Director |
2017-06-16 16:54:42 | 7,568 0 |
7,568 | Form 4 |
29 | KELLER WILLIAM R Director |
2014-12-08 16:59:20 | 7,276 0 |
7,276 | Form 4 |
30 | JACKSON JERRY T Former Director Director |
2005-03-10 15:47:25 | 6,300 0 |
6,300 | Form 4 |
31 | Veneman Ann M Director |
2017-09-05 19:28:00 | 5,480 0 |
5,480 | Form 4 |
32 | BOESS CARSTEN Former CFO |
2005-06-29 16:52:51 | 5,000 0 |
5,000 | Form 4/A |
33 | NORBY R DOUGLAS Director |
2017-05-12 18:01:36 | 4,906 0 |
4,906 | Form 4 |
34 | BURNS M MICHELE Director |
2017-05-12 18:01:58 | 4,353 0 |
4,353 | Form 4 |
35 | ROLLINS SCOTT A Sr. VP Drug Dev. & Proj. Man. |
2005-06-08 16:21:31 | 3,100 0 |
3,100 | Form 4 |
36 | MOTOLA NANCY SVP, Regulatory & QA |
2005-08-31 16:01:25 | 0 3,085 |
3,085 | Form 5 |
37 | LINK MAX Director |
2014-05-07 16:49:56 | 2,785 0 |
2,785 | Form 4 |
38 | Coissac Patrice SVP & Pres. ALXN Pharma Int'l |
2012-11-02 16:30:11 | 1,118 0 |
1,118 | Form 4 |
39 | COUGHLIN CHRISTOPHER J Director |
2021-07-23 16:54:11 | 0 0 |
0 | Form 4 |
40 | SARIN ARADHANA EVP, CFO |
2021-07-23 16:52:30 | 0 0 |
0 | Form 4 |
41 | FRIEDMAN PAUL A Director |
2021-07-23 16:51:08 | 0 0 |
0 | Form 4 |
42 | Reinsdorf Judith A Director |
2021-07-23 16:49:49 | 0 0 |
0 | Form 4 |
43 | Dunsire Deborah Director |
2021-07-23 16:48:29 | 0 0 |
0 | Form 4 |
44 | Carino Tanisha EVP & CCAO |
2021-07-23 16:47:18 | 0 0 |
0 | Form 4 |
45 | Mollen John T Director |
2021-07-23 16:45:40 | 0 0 |
0 | Form 4 |
46 | Brennan David R Director |
2021-07-23 16:44:13 | 0 0 |
0 | Form 4 |
47 | Goff Brian EVP & Chief Commercial Officer |
2021-07-23 16:42:07 | 0 0 |
0 | Form 4 |
48 | Chiniara Ellen EVP & Chief Legal Officer |
2021-07-23 16:40:38 | 0 0 |
0 | Form 4 |
49 | Bazarko Daniel SVP, Controller, CAO |
2021-07-23 16:39:10 | 0 0 |
0 | Form 4 |
50 | Franchini Indrani Lall EVP, Chief Compliance Officer |
2021-07-23 16:37:55 | 0 0 |
0 | Form 4 |
51 | Nader Francois Director |
2021-07-23 16:36:17 | 0 0 |
0 | Form 4 |
52 | Rummelt Andreas Director |
2021-07-23 16:34:17 | 0 0 |
0 | Form 4 |
53 | ORLOFF JOHN J EVP, Research & Development |
2021-07-23 16:29:42 | 0 0 |
0 | Form 4 |